Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients-Reference-Cited by-同舟云学术

Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients

Published:2013-06-12 Issue:7 Volume:88 Page:556-559
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Adès Lionel¹,Chevret Sylvie²,Raffoux Emmanuel²,Guerci-Bresler Agnes³,Pigneux Arnaud⁴,Vey Nobert⁵,Lamy Thierry⁶,Huguet Francoise⁷,Vekhoff Anne⁸,Lambert Jean-Francois⁹,Lioure Bruno¹⁰,de Botton Stephane¹¹,Deconinck Erick¹²,Ferrant Augustin¹³,Thomas Xavier¹⁴,Quesnel Bruno¹⁵,Cassinat Bruno²,Chomienne Christine²,Dombret Hervé²,Degos Laurent²,Fenaux Pierre¹,

Affiliation:

1. Hopital Avicenne, université paris 13; Bobigny France

2. Hopital Saint Louis, univertsité paris 5; Paris France

3. Centre hospitalo-universitaire Nancy; France

4. Centre hospitalo-universitaire Bordeaux; France

5. Institut Paoli Calmettes; Marseille France

6. Centre hospitalo universitaire de Rennes; France

7. Centre hospitalo-universitaire de Toulouse; France

8. Hospital Saint Antoine; Paris France

9. Hospital universitaire; Lausanne Switzerland

10. Centre hospitalo universitaire Strasbourg; France

11. Institut Gustave-Roussy; Villejuif France